Vincent Pham Selected for Inaugural EDGe T32 Cancer Training Program
SAN ANTONIO, Texas — The Huang Lab at the Mays Cancer Center at UT Health San Antonio announces that Vincent Pham, Cancer Biology PhD Candidate, has been selected for the inaugural cohort of the NCI T32 Epigenetics, DNA Repair and Genomics (EDGe) Training Program in Cancer, T32CA279363.
Vincent’s appointment began on October 1, 2024, and runs through September 30, 2025, with a second year contingent on progress. The program provides stipend support, partial tuition and fee coverage, structured coursework, career development, and mentored research. Trainees receive support to present at national cancer conferences and are expected to pursue an individual fellowship such as the NIH F31 during the first year.
“The EDGe program aligns with Vincent’s rigorous approach to discovery and translation,” said Dr. Gang Huang, principal investigator. “This training will deepen his expertise in epigenetics and genomics while advancing our lab’s research.”
“I am honored to join the inaugural cohort,” said Vincent. “The curriculum, mentorship, and expectations fit my research on tumor immunology and cancer‑associated cachexia. I look forward to contributing and learning.”
The EDGe Training Program is led by Program Director Dr. Alex Bishop, PhD and Co‑Director Dr. Robin Leach, PhD. Trainees participate in advanced coursework, journal clubs, seminars, experimental design workshops, and an annual joint training retreat.
About the Huang Lab
The Huang Lab at UT Health San Antonio is a basic and translational cancer research group within the MD Anderson Mays Cancer Center at UT Health San Antonio. Our team integrates hematology and solid tumor biology with immunology and metabolism to uncover mechanisms and design interventions. We advance cell and biologic therapies, including CAR T‑cell approaches for solid tumors. We also conduct research in trauma and military health. We move discoveries toward clinical impact through product development and collaborations with clinicians and industry. Education and mentorship are core to our mission. We train students, postdoctoral fellows, and early‑career scientists in rigorous, multidisciplinary research. Together, we aim to deliver therapies and technologies that improve patient outcomes.